Enhancement by caffeine of neocarzinostatin cytotoxicity in murine leukemia L1210 cells. 1979

K Tatsumi, and M Tashima, and S Shirakawa, and T Nakamura, and H Uchino

Posttreatment incubation with nontoxic doses of caffeine resulted in enhancement of cell lethality and inhibition of cell growth in L1210 mouse leukemia cells which had been exposed to a protein antibiotic, neocarzinostatin. In addition, caffeine treatment appeared to inhibit the eventual maturation of newly synthesized DNA in L1210 cells following exposure to this antibiotic. These results, indicating the existence of caffeine-sensitive repair in L1210 leukemia cells treated with neocarzinostatin, provide further evidence for DNA damage as a mechanism of the cytocidal action of the antibiotic.

UI MeSH Term Description Entries
D007939 Leukemia L1210 An experimental LYMPHOCYTIC LEUKEMIA of mice. Leukemia L 1210,L 1210, Leukemia,L1210, Leukemia
D009353 Zinostatin An enediyne that alkylates DNA and RNA like MITOMYCIN does, so it is cytotoxic. Neocarzinostatin
D002110 Caffeine A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling. 1,3,7-Trimethylxanthine,Caffedrine,Coffeinum N,Coffeinum Purrum,Dexitac,Durvitan,No Doz,Percoffedrinol N,Percutaféine,Quick-Pep,Vivarin,Quick Pep,QuickPep
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004260 DNA Repair The removal of DNA LESIONS and/or restoration of intact DNA strands without BASE PAIR MISMATCHES, intrastrand or interstrand crosslinks, or discontinuities in the DNA sugar-phosphate backbones. DNA Damage Response
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug

Related Publications

K Tatsumi, and M Tashima, and S Shirakawa, and T Nakamura, and H Uchino
December 1990, Pharmaceutical research,
K Tatsumi, and M Tashima, and S Shirakawa, and T Nakamura, and H Uchino
July 1977, Cancer research,
K Tatsumi, and M Tashima, and S Shirakawa, and T Nakamura, and H Uchino
January 1993, Cancer chemotherapy and pharmacology,
K Tatsumi, and M Tashima, and S Shirakawa, and T Nakamura, and H Uchino
January 1978, Biokhimiia (Moscow, Russia),
K Tatsumi, and M Tashima, and S Shirakawa, and T Nakamura, and H Uchino
June 1981, Research communications in chemical pathology and pharmacology,
K Tatsumi, and M Tashima, and S Shirakawa, and T Nakamura, and H Uchino
February 1987, The Journal of pharmacology and experimental therapeutics,
K Tatsumi, and M Tashima, and S Shirakawa, and T Nakamura, and H Uchino
January 1983, Drug and chemical toxicology,
K Tatsumi, and M Tashima, and S Shirakawa, and T Nakamura, and H Uchino
January 1994, Archives of biochemistry and biophysics,
K Tatsumi, and M Tashima, and S Shirakawa, and T Nakamura, and H Uchino
January 1998, Oncology reports,
K Tatsumi, and M Tashima, and S Shirakawa, and T Nakamura, and H Uchino
December 1993, Cancer research,
Copied contents to your clipboard!